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Abstract
Murine Pre-B lymphocytes with experimentally acti-
vated MycER show both chromosomal and extrachro-
mosomal gene amplification. In this report, we have
elucidated the size, structure, and functional compo-
nents of c-Myc–induced extrachromosomal elements
(EEs). Scanning electron microscopy revealed that EEs
isolated from MycER-activated Pre-B+ cells are an
average of 10 times larger than EEs isolated from
non-MycER–activated control Pre -B cells. We
demonstrate that these large c-Myc–induced EEs
are associated with histone proteins, whereas EEs
of non-MycER–activated Pre B cells are not.
Immunohistochemistry and Western blot analyses
using pan-histone–specific, histone H3 phosphoryla-
tion–specific, and histone H4 acetylation–specific
antibodies indicate that a significant proportion of
EEs analyzed from MycER-activated cells harbors
transcriptionally competent and/or active chromatin.
Moreover, these large, c-Myc–induced EEs carry
genes. Whereas the total genetic make-up of these
c-Myc–induced EEs is unknown, we found that 30.2%
of them contain the dihydrofolate reductase (DHFR )
gene, whereas cyclin C (CCNC ) was absent. In
addition, 50% of these c-Myc–activated Pre-B+ EEs
incorporated bromodeoxyuridine (BrdU), identifying
them as genetic structures that self -propagate. In
contrast, EEs isolated from non-Myc–activated cells
neither carry the DHFR gene nor incorporate BrdU,
suggesting that c-Myc deregulation generates a new
class of EEs.
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Introduction
c-Myc is an important regulator of growth, proliferation,
differentiation, and development. Deregulation of the c-Myc
oncoprotein has been reported in apoptosis ( for review,
see Ref. [2 ] ), cellular transformation ( for reviews, see, Refs.
[3–5] ), and in malignancies of lymphoid and nonlymphoid
origin [6–9]. c -Myc is involved in repressing, enhancing, and
initiating transcription [5–11]. Recent evidence links c-Myc
to angiogenesis [12–14].
The deregulation of c-Myc is a common feature in many
tumors, where it is frequently found translocated and/or
amplified [15,16]. c -Myc promotes replication [17] and
genomic instability [18–25]. This study addresses the
mechanisms of c-Myc–dependent genomic instability.
Genomic instability refers to genetic changes that affect
the normal organization and function of genes and
chromosomes. These alterations may be structural or
numerical. Factors such as genotoxic stimuli, growth
factors, and oncogenic deregulation are potent inducers of
genomic instability ( for reviews, see, Refs. [26–28] ). It
was found previously that the deregulation of c-Myc
expression under both in vitro and in vivo conditions leads
to karyotypic (chromosomal) and locus-specific genomic
instability [18–25]. Earlier, we showed c-Myc–dependent
amplification of the dihydrofolate reductase (DHFR ) gene
for hamster and rat fibroblasts, as well as in human breast
cancer and mouse plasmacytoma cell lines [20]. DHFR
was also amplified in vivo during the first week of c-Myc–
dependent induced plasmacytomagenesis in BALB/c mice
[29], as well as in fully developed primary mouse
plasmacytomas [30]. More recently, we have described
the c-Myc–dependent generation of extrachromosomal
elements (EEs) in a mouse Pre-B lymphocyte cell line
(designated Pre-B) [22,31,32]. To date, this mouse cell
line has been shown to carry the following amplified genes
extrachromosomally and intrachromosomally upon c-Myc
deregulation: DHFR [31 ], cyclin D2 (CCND2) [21 ],
ribonucleotide reductase R2 (R2 ) [22], and ornithine
decarboxylase (ODC ) [33 ].
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EEs have been found in all cells, including primary cells
[34]. For immortalized human fibroblasts, EEs range in
number from 10 to 60 molecules per cell and average 0.8 m
in diameter [34]. These smaller circular molecules are also
called small polydispersed DNA (spcDNA) and carry
repetitive DNA sequences [35,36]. In contrast, large
(averaging 1–2 m in diameter) chromatin structures, called
episomes and double minutes, which are included in the
broad category of EEs [34], have long been known to harbor
amplified genes ( for review, see Refs. [37–40]). This class
of EEs is larger than 250 kb in size and can number in the
thousands, depending on which tumor cell line or tumor is
analyzed. In 1979, Kaufman et al. [41] first showed the
generation of EEs carrying amplified DHFR in unstable
methotrexate-resistant mouse cell lines. More recent stud-
ies on EEs have shown that these circular double-stranded
DNA molecules are prevalent in cancer cells and harbor
oncogenes, in addition to drug resistance genes [42–44].
There have been very few studies addressing the
mechanism of EE formation and whether or not these
molecules function as ‘‘active chromatin units.’’ Studies by
Itoh and Shimizu [45] showed that EEs localize to the
nuclear interior upon entry of the cell into S-phase.
Interestingly, Solovei et al. [46] showed that EEs found in
the neuroblastoma cell line HD-N-16 associate with the
interchromosomal domain ( ICD). It was suggested that this
ICD harbors macromolecular complexes that are involved in
transcription, splicing, DNA replication, and repair [47,48].
However, compelling data on these cellular functions and
their association with EEs have been lacking.
Here, we have analyzed for the first time the size,
structure, and functional composition of c-Myc–induced
EEs. We report that EEs generated in MycER-activated [1]
Pre-B cells carry competent and/or active chromatin. In
addition, we show that only c-Myc–induced EEs harbor
genes such as DHFR. Moreover, we describe that these c-
Myc–induced EEs have the potential to replicate, whereas
EEs isolated from non–c-Myc–activated Pre-B cells do not
have this ability. The genetic composition of c-Myc–induced
EEs is nonrandom; DHFR is present on EEs whereas cyclin
C is not. Importantly, EEs from non–c-Myc–induced control
cells do not contain these genes.
Materials and Methods
Cell Lines
Pre-B mouse lymphocyte line (designated Pre-B)
[21,22] and Pre-B (abl ) cells [49] were cultured in RPMI
1640 medium supplemented with 10% (vol /vol ) fetal bovine
serum, 1% (vol /vol ) sodium pyruvate, 50 IU/ml penicillin,
50 g/ml streptomycin, 5.5105 M b -mercaptoethanol,
and 2 mM glutamine (Canadian Life Technologies, Burling-
ton, Ontario, Canada). The Pre-B cells were seeded for
24 hours, followed by c-Myc activation for 72 hours using
100 M 4-hydroxytamoxifen (4-HT) (Sigma, Oakville,
Ontario, Canada) dissolved in 100% ethanol. The 4-HT–
activated cells were designated Pre-B+ and the non-
activated Pre-B cells were designated Pre-B , which in
MycER activation experiments received an equal volume of
100% ethanol. MycER activation was determined as
described earlier, using quantitative fluorescent immunohis-
tochemistry ( fIHC) techniques [22].
fIHC of Purified EEs
fIHC was performed as described previously on Pre-
B+ and Pre-B EEs [31], which were isolated using the
Hirt procedure [50]. The purity of the EE preparations
was examined using the fluorochrome 40,60 -diamidino-2-
phenylindole (DAPI), which specifically intercalates into
AT-rich regions of DNA. Subsequent analysis of EEs from
Hirt extracts by fluorescent microscopy identified whether
or not there was genomic contamination. Scanning
electron microscopy (SEM) was used to confirm these
staining results. As a result, EE preparations containing
DNA fibers, as detected by either of the two methods,
were excluded from our analysis [31]. Only purified
EEs devoid of contamination by genomic or apoptotic
DNA were used in all of the experimental procedures
listed below.
Where indicated, cross- linking of EEs and protein was
carried out for 10 minutes at room temperature with 1%
formaldehyde in 1 phosphate-buffered saline/50 mM
MgCl2. Sheep anti -core histone antibody (United States
Biological, SwampScott, MA) was used at 5 ng per slide
and visualized with a FITC-conjugated donkey anti–sheep
IgG antibody (Sigma) at 2.75 ng per slide. The anti–
histone H3 phosphorylation–specific antibody used is a
histone H3 phosphoserine monoclonal antibody from Juan
et al. [51]. It was used at 4.0 ng per slide and visualized
with a Texas Red conjugated goat anti–mouse IgG1
antibody (Southern Biotechnology Associates, Birmingham,
AL) at 2.5 ng per slide. Image acquisition was performed
using a Zeiss Axioplan2 microscope (Carl Zeiss Canada,
Toronto, Ontario, Canada) under a 63 oil immersion
objective and a UV filter. The images were assessed using
Northern Eclipse 5.0 software (Empix Imaging, Missis-
sauga, Ontario, Canada) and a Hamamatsu CCD camera
(East Syracuse, NY).
Bromodeoxyuridine (BrdU) Replication and Gene
Expression Analysis of EEs
A total of 2.0106 Pre-B cells was stimulated with
100 M 4-HT or an equal volume of 100% ethanol and
grown for 72 hours, followed by a BrdU pulse (Sigma) at
a concentration of 10 M for 30 minutes before harvest-
ing. The EEs were then isolated using the Hirt extraction
procedure [50] as outlined previously [31,53]. The
purified EEs were subjected to fluorescent in situ hybrid-
ization (FISH) as described previously [31], using the
following probes: dihydrofolate reductase (DHFR ) [20]
and cyclin C [20 ] conjugated to either digoxigenin (DIG)
or biotin, respectively. The DIG- labeled probes were
detected using a 1:200 dilution of anti–DIG-FITC anti-
body (Roche Diagnostics, Laval, Quebec, Canada),
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whereas the biotin- labeled probes were detected using a
1:200 dilution of monoclonal mouse anti–biotin antibody
(Roche Diagnostics), followed by a 1:400 dilution of goat
anti–mouse IgG Texas Red secondary antibody (South-
ern Biotechnology, Associates, Birmingham, AL). In
parallel, BrdU that was incorporated into the EEs was
detected as reported previously [32]. Analyses were
performed using a Zeiss Axiophot microscope (Carl Zeiss
Canada) under a 63 oil immersion objective and UV/
FITC and Texas Red filters coupled to a Photometrics
CH250/A CCD camera (Eastman Kodak, Rochester, NY).
The images were assessed using the IP Lab version 3.1
software (Scanalytics, Fairfax, VA).
Sodium Dodecyl Sulphate Polyacrylamide Gel
Electrophoresis (SDS-PAGE) and Silver Staining
of SDS-PAGE Gels
Silver staining of 15% SDS-PAGE gels was performed
as outlined by the manufacturer of the silver stain oxidizer,
silver reagent, and developer solutions (Bio-Rad Labora-
tories, Hercules, CA). Fifteen percent SDS-PAGE gels
were made, loaded, and electrophoresed as outlined by
Laemmli [52].
Protein gels for silver stain and Western blot analysis
were loaded with 2 g of low molecular weight standard;
either 5 or 10 g of total histone extract from chicken
erythrocytes; 40 g of ovalbumin and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH); 20 g of bovine
serum albumin (BSA) and anti–mouse whole IgG anti-
body; either 25 l, 50 l, 40 g, or 0.5 g (based on
DNA concentration) of Pre-B+ / EEs; and 0.5 g
(based on DNA concentration) of C57BL6 mouse
splenocyte EEs.
Western Blot Analysis of EEs
Formaldehyde fixed or nonfixed Pre-B / + and Pre-B
(abl ) / + EEs as well as EEs isolated from primary
C57BL6 mouse splenocytes were isolated using the Hirt
procedure [50] and subjected to three rounds of dialysis
using ddH2O as the exchange buffer. Dialysis tubing
(Canadian Life Technologies) (3 /4 in. diameter; 12,000
kDa molecular weight exclusion limit ) was used to dialyze
a large volume of EEs, followed by their concentration
using a Microcon 50 (50,000 kDa cutoff ) concentrator
(Amicon, Bedford, MA). After centrifuging repeatedly at
13,000 rpm, the EEs were examined for genomic
contamination as described above. The concentration of
the protein containing EEs was then determined by using
either a standard Bradford protein assay [54] using BSA
(Sigma) as a concentration standard, or the DNA
concentration was determined by using a fluorometric
assay. In this assay, the DNA concentration of the EEs
was determined by resuspending a purified EEs aliquot in
a buffer containing 25 mM sodium phosphate buffer
(monobasic) and 0.01 M DAPI, pH 7.5. The plasmid
pcDNA3 (Invitrogen, Carlsbad, CA) was used as the
concentration standard. The concentration was then
determined by using the Titerek Fluoroskan II fluorometer
(Labsystems, McLean, VA) at an absorbance/emission
spectra specific to DAPI. The measured fluorescence was
then analyzed using Spectrosoft software (Labsystems).
Depending on the Western blot experiment performed,
either a 40-g quantity of protein containing EEs (as
determined by the Bradford assay) or 0.5 g of EEs (as
determined by the fluorometric assay) was then loaded on
a 15% SDS-PAGE gel, along with total histone isolated
from chicken erythrocytes. Negative controls such as
ovalbumin (Sigma ImmunoChemicals, Oakville, Ontario,
Canada), GAPDH (Sigma), BSA (Sigma), and anti–
mouse IgG (Sigma) were loaded. After electrophoresis of
the protein samples for 2 hours at 100 V, protein was
transferred to a Hybond-C Super membrane (Amersham
Pharmacia Biotechnologies, Piscataway, NJ) using a Bio-
Rad (Mississauga, Ontario, Canada) semidry transfer
apparatus Transblot SD. To optimize the transfer of highly
basic proteins such as histones, a 3- [cyclohexylamino] -
1-propanesulfonic acid (CAPS) transfer buffer was
utilized (25 mM CAPS, pH 10, 20% methanol ), allowing
overnight transfer at 50 V (Bio-Rad). Blocking was then
performed the next day for 15 minutes using 3% skim milk
powder (wt /vol ) in 1 /0.2% Tween-20 buffer. For detec-
tion of acetylation-specific species of H4 histone, a 1:1000
unit dilution of rabbit penta H4-hyperacetylated specific
antibody (Upstate Biotechnology, Hornby, Ontario, Can-
ada) was used for 1-hour incubation under rocking
conditions, followed by three 5-minute washes in 1
TBS/0.2% Tween-20 solution. This was followed by
detection using a rabbit -specific IgG antibody conjugated
to horseradish peroxidase (concentration/ time specified by
the company; ECL Kit, Amersham Pharmacia Biotechnol-
ogies). Visualization of the Western blot was done using
Hyperfilm ECL high-performance chemiluminescence film.
The film was then developed using the CP1000 developer
(AGFA, Etobicoke, Ontario, Canada).
SEM of EEs
The procedure for SEM of EEs was done as outlined
previously [55,56], except for the following changes.
Suspensions of Hirt - isolated EEs mixed with an equal
volume of fresh methanol /acetic acid (3:1 vol /vol ) were
dropped on cooled cover slips and then permitted to dry. As
indicated, some EE samples were treated for 24 hours at
568C with 100 g (10 g/l ) of proteinase K before SEM
analysis. The coverslip was then plunged into 50% acetic
acid solution for 1 second followed by subsequent 1-
second incubations in coplin jars filled with a mixture of
ethanol:distilled water:methanol:acetic acid (20:20:9:1 parts
by volume), 70%, 90%, and 100% ethanol solutions,
respectively. Coverslips were then cut with a diamond
pencil and mounted on stubs using liquid carbon. The
samples were then coated with 15 nm each of Gold in a
Hummer VII (Anatech, Alexandria, VA) sputter coater and
analysed at 10 kV with a JEOL JSM-6400 scanning
electron microscope (Peabody, MA) and photographed on
Kodak TMAX black-and-white film.
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Results
Ultrastructural Analysis of EEs Isolated from MycER-
Activated and Control Pre-B Cells
SEM was employed to examine the ultrastructure of
c-Myc–induced EEs. A direct comparison of EEs isolated
from non–c-Myc deregulated cells (Pre-B ) and of EEs
isolated from c-Myc deregulated cells (Pre-B+ ) was
performed. The Pre-B EEs were 0.1–0.2 m in diameter
(Figure 1, A and B ), whereas c-Myc–activated Pre-B+ EEs
ranged in size from 1.0 to 20 m (Figure 1C ), with 90% of
Pre-B+ EEs being approximately 1.0 m in diameter. Thus,
the EEs isolated from MycER-activated cells were an
average of 10- fold larger in diameter than Pre-B EEs
isolated from nonactivated cells, whereas some Pre-B+
EEs were up to 200- fold larger.
Our subsequent analyses of c-Myc–induced EEs
focused on their protein content, their transcriptional activity,
and genetic composition, as well as on their potential
to replicate.
Identification of Histone Proteins on c-Myc–Induced
Pre-B+ EEs
The protein- like ‘‘globular’’ structures on Pre-B+ EEs
were not usually apparent on the Pre-B EEs (Figure 1,
A–C ). Previous reports have shown that smaller EEs found
in primary cells do not contain proteins on their surface [34].
However, because previous SEM studies have acknowl-
edged similar structures on EEs isolated from tumorigenic
cells as possibly being composed of proteins [55,56], we
wanted to determine the nature of the ‘‘globular’’ structures
found on c-Myc–induced Pre-B+ EEs. Therefore, we
pretreated samples of Pre-B+ EEs with proteinase K before
SEM analysis. Subsequent analysis showed that the overall
structure of the Pre-B+ EEs disintegrated as a result of
proteinase K treatment, suggesting that Pre-B+ EEs carry
proteins (data not shown).
Histone proteins constitute one of the major components
of nuclear chromatin material ( for review, see Ref. [57] ).
Many EEs can replicate autonomously [38–40] and
coordinately move with mitotic chromosomes [58], such
that they can become accessible to the cellular replication
and transcription machinery. Therefore, it is very likely that
some of the protein components of EEs are core histone
proteins ( i.e., H2A, H2B, H3, and H4) ( for review, see
Ref. [57] ). To date, there has been no identification of the
protein components found on EEs, except for the identi-
fication of lamin B found on EEs that were isolated from
COLO 320DM cells [59].
To examine the potential presence of histone proteins
on c-Myc–induced EEs (Pre-B+ EEs), we performed
fIHC on purified Pre-B+ EEs. Using a pan-histone
antibody, which detects the core histone proteins, we
identified that 25.0±3.3% of Pre-B+ EEs (Figure 2, A–D,
see arrows) contain core histone protein (Figure 2B, green
signals, see arrows, and Table 1). To determine whether
the Pre-B+ EEs contained active chromatin, we performed
fIHC using an anti–histone H3 phosphorylation (H3P)–
specific antibody. This antibody detects a modification of
histone H3 that is associated with transcriptionally active
chromatin [51]. Our data show that 20.0±3.2% of Pre-B+
EEs contained H3P protein (Figure 2C, red signals, see
arrows, and Table 1). Eighty percent of the H3P signal
overlayed with the core histone signal (Figure 2D, see
arrows). When EEs in non–c-Myc–activated control cells
Figure 1. SEM of Pre -B / + EEs. Representative examples of EEs isolated
from Pre -B or Pre -B+ cells (A, B, and C, respectively ). Arrows in (A ) and
(B ) point to small protein - free EEs (see alsoRef. [ 34 ] ). Arrows in (C ) point to
examples of ‘‘globular’’ structures found on the surface of the c -Myc– induced
Pre -B+ EEs. The magnification of the structures shown in (A )– (C ) is
30,000, 30,000, and 3500, respectively. The scale bar found at the
bottom of (A ) and (B ) represents 1 m, while the scale bar on the bottom of
panel C represents 10 m.
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(Pre-B EEs) were analyzed, we found that only
9.3±2.4% of the EEs contain core histone (Table 1). In
addition, only 9.0±1.5% of Pre-B EEs analyzed showed
a H3P-specific signal (Table 1). These data suggest that
the majority of c-Myc–induced EEs carry transcriptionally
competent and/or active chromatin.
To eliminate the possibility that 4-HT, used to activate the
Myc-ER construct in the Pre-B cells (Materials andMethods
section), caused the generation of transcription-associated
histones on these EEs, we performed fIHC on EEs isolated
from Pre-B cells that did not harbor the MycER construct.
The cells examined, designated Pre-B (abl ), contained,
similar to the Pre-B cells studied here [21], the Abelson
leukemia virus [49]. A total of 11.6±5.2% of the EEs isolated
from non–4-HT–treated Pre-B (abl ) cells contained core
histone protein and 10.7±2.8% of these EEs show H3P
specific signal (Table 1). Similarly, 7.5±2.3% of EEs isolated
from 4-HT–treated Pre-B (abl ) cells contained core histone
protein and 6.8±2.8% of these EEs showed a H3P-specific
signal (Table 1). In conclusion, histone proteins were found
at low frequencies on Pre-B EEs and Pre-B (abl ) / +
EEs irrespective of the treatment with 4-HT. In contrast, a
significant amount of c-Myc–induced Pre-B+ EEs carried
histones. Thus, 4-HT does not contribute towards the
generation of EEs, but rather the deregulation of c-Myc
induces the generation of EEs with immunohistochemical
evidence of active chromatin.
Figure 2. Immunohistochemistry of EEs isolated from nonformaldehyde - treated Pre -B+ cells using both core histone and H3 phosphorylation–specific antibodies.
(A ) DAPI - stained Pre -B+ EEs. (B ) Pre -B+ EEs that were detected with a fluorescein (FITC ) - conjugated core histone antibody. (C ) Pre -B+ EEs that were
detected with a Texas Red (TR )–conjugated H3 phosphorylation–specific antibody. (D ) Overlay of panels A–C. The arrows shown in each panel depict
representative examples of EEs that are highlighted by either DAPI or histone antibodies. Due to the overlay in (D ), each dot appears white in color. This represents
a colocalization of signal from panels A to C. Inserts within the individual pictures highlight the respective EEs. For quantification of these findings, see Table 1.
Table 1. Core Histone and H3-Phosphorylated Protein Found on EEs.












Pre-B   9.3±2.4 9.0±1.5
+  25.0±3.3 20.0±3.2
 + 28.7±2.0 28.0±1.3
+ + 71.0±10.6 62.0±4.2
Pre-B (abl)   11.6±5.2 10.7±2.8
+  7.5±2.3 6.8±2.8
 + 28.1±2.1 18.4±6.5
+ + 25.3±2.6 9.0±2.7
This table outlines all the different EE preparations that were used for these
studies along with their corresponding core histone and H3 phosphorylation
protein levels as measured by fIHC. The percentages and standard errors
calculated are based on a total number of 300 EEs that were counted for
each sample. The analysis of 100 EEs in each of three individual experiments
was performed.
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Effects of Formaldehyde Cross-Linking of Pre-B Cells on
the Amount of Histone-Carrying EEs Recovered During Hirt
Extraction of EEs
To determine the relative proportions of core histone
protein and H3P that remain associated with EEs after Hirt
isolation [50], we cross- linked EEs and protein prior to the
Hirt isolation procedure using formaldehyde (Materials and
Methods section). Formaldehyde leads to cross- linking of
proteins to DNA [60]. To this end, EE isolation and fIHC
analysis were carried out following cross- linking with 1%
formaldehyde. As a result, 71.0±10.6% of the Pre-B+ EEs
analyzed contained core histone protein (Figure 3B, see
arrows, and Table 1). In addition, 62.0±4.2% of the Pre-B+
EEs contained H3P-specific protein (Figure 3C, see arrows,
and Table 1) and the H3P signals overlayed with 85% of the
core histone signals (Figure 3D, see arrows). In contrast,
only 28.7±2.0% of Pre-B EEs that were isolated from
formaldehyde-pretreated Pre-B cells contained core his-
tone protein (Table 1) and 28.0±1.3% of these EEs
contained H3P-specific protein (Table 1). Interestingly,
Pre-B (abl ) EEs isolated from formaldehyde cross- linked
4-HT- treated cells gave similar results to Pre-B EEs,
whereby 25.3±2.6% of EEs contained core histone protein
and 9.0±2.7% EEs contained H3P-specific protein. These
data suggest that the formaldehyde cross- linking procedure
increases the amount of histone protein bound to EEs,
providing evidence that the Hirt isolation procedure caused a
loss in the number of histone-bound EEs. In addition, using
this experimental approach, we have shown that the histone
protein content of EEs isolated from either formaldehyde-
treated Pre-B cells or Pre-B (abl ) cells is not affected by
pretreating these cells with 4-HT. Therefore, c-Myc activa-
tion specifically affects the number of core histone and H3P
histone proteins found on EEs isolated from Pre-B+ cells.
Further Molecular Analyses of Histone Proteins in c-Myc–
Induced Pre-B+ EEs
Because the fIHC data suggest that the Pre-B+ EEs
contain core histone proteins, we set out to analyze the
histone protein content further using Western blot analysis.
Because formaldehyde pretreatment of cells increased the
amount of core histone protein that was identified by fIHC, all
further analyses were performed using EEs isolated from
Pre-B cells that had been pretreated with formaldehyde.
Silver stain analysis of four independent samples of Pre-
B+ EEs revealed the presence of major protein complexes
Figure 3. Immunohistochemistry of EEs isolated from formaldehyde - treated Pre -B+ cells using both core histone and H3 phosphorylation–specific antibodies.
The fIHC experiment was performed and analyzed as outlined for Figure 2. (A ) – (D ) represent similar pictures as in Figure 2, except the EEs used in this experiment
were isolated from formaldehyde - treated Pre -B+ cells. Inserts within the individual pictures highlight the respective EEs. For quantification of these findings, see
Table 1.
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at approximately 14 kDa, which were absent in four
corresponding samples of Pre-BEEs (Figure 4A, lanes
1–4 and 5–8, respectively, see arrow). This major protein
complex migrated at the same molecular weight (14 kDa) as
total histone extract isolated from chicken erythrocytes
(Figure 4A, lane 9). Silver stain analysis of Pre-B and
Pre-B+ EEs samples also identified many less abundant
proteins ranging in molecular weight from less than 14 kDa to
greater than 66 kDa.
We chose to study the 14-kDa proteins on EEs due to
their predominance in Pre-B+ cells and their absence in
Pre-B cells. An antibody specific to the modified H4-
acetylated histone protein was used for this analysis
because it was previously shown that this H4 histone
modification is associated with transcriptionally active
chromatin [60]. We did not use the histone H3P antibody
because it does not recognize histone H3P protein in
Western blot analyses. We found that H4-acetylated histone
protein was present in the Pre-B+ EE sample (Figure 4B,
lane 6), whereas no H4-acetylated protein was detected in
Pre-B EEs (Figure 4B, lane 7). The specificity of the H4
acetylation–specific antibody was confirmed by identifying
the IgG heavy chains (50 kDa) and the IgG light chains (25
kDa) of an anti–mouse IgG antibody that was used to
reprobe the original blot (Figure 4C ).
We next performed Western analyses using EE samples
based on their DNA content (Figure 4D ). Under these
experimental conditions, we observed a faint band for Pre-
B EEs, indicating that Pre-B EEs contain some H4-
acetylated protein (Figure 4D, lane 5). A stronger band was
detected for Pre-B+ EEs (Figure 4D, lane 6). To investigate
whether the immortalization process of the Pre-B cells might
be the reason why some H4-acetylated protein was found in
the Pre-B samples [34], we examined EEs isolated from
primary mouse C57BL6 splenocytes. No measurable
amount of histone H4-acetylated protein was detected in
this sample (Figure 4D, lane 7). To control for loading, the
gel in Figure 4D was silver -stained (Materials and Methods
section) (Figure 4E ). Equal loading was observed for Pre-
B , Pre-B+, and C57BL6 EEs, respectively (Figure 4E,
lanes 5–7, respectively). We conclude that c-Myc–induced
Pre-B+ EEs contain significantly more H4-acetylated
protein than Pre-B EEs.
c-Myc–Induced EEs Carry Genes and Can Replicate
To prove that not only Pre-B+ EEs contain transcrip-
tionally competent and/or active DNA but also genes, we
performed FISH of EEs (FISH-EEs) [31] on both Pre-B
and Pre-B+ EEs. To assess their potential to replicate, we
pulse- labeled the cells with BrdU prior to the isolation of
Figure 4. Silver stain and Western analysis of Pre -B / + and primary spleen cell EEs using H4 acetylation–specific antibody. (A ) Fifteen percent silver - stained
SDS-PAGE gel. Pre -B+ /  EEs ( lanes 1–4 and 5–8, respectively ), histone extract ( lane 9 ), and low molecular weight standard were loaded as outlined in the
Materials and Methods section. (B ) Western blot using an anti – rabbit H4 acetylation–specific antibody. Low molecular weight standard, histone extract, ovalbumin,
GAPDH, anti –mouse whole IgG antibody ( lanes 1–5, respectively ), and Pre -B+ /  EEs ( lanes 6 and 7, respectively ) were loaded as outlined in the Materials and
Methods section. (C ) Western blot of the same membrane used in (B ), but it was stripped and reprobed with an anti –mouse whole IgG antibody. (D ) Western blot
using H4 acetylation–specific antibody. Histone extract and BSA ( lanes 1 and 2, respectively ), no sample ( lanes 3 and 4 ), Pre -B EEs, Pre -B+ EEs, and
C57BL6 mouse spleen EEs ( lanes 5–7, respectively ) were loaded as outlined in the Materials and Methods section. (E ) Silver - stained 15% SDS-PAGE gel of the
Western blot shown in panel D.
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EEs (Materials and Methods section). The simultaneous
analysis of BrdU incorporation signals and DHFR FISH
signals allowed us to conclude that: 1) Pre-B+ EEs, but
not Pre-B EEs, incorporated BrdU; 2) Pre-B+ EEs that
contained BrdU also contained the DHFR gene, but not the
cyclin C control gene; and 3) in contrast, Pre-B EEs did
not incorporate BrdU, and they did not contain the DHFR
gene (Table 2). We conclude that c-Myc activation in
mouse Pre-B cells leads to the generation of EEs that
contain DHFR, which has the ability to replicate. It is likely
that other genes are also present on these EEs because
previous studies have identified genes such as R2 [22]
and cyclin D2 (CCND2 ) [21] as being found amplified on
Pre-B+ EEs. However, only the DHFR gene was analyzed
in this study.
Discussion
In 1990, Gaubatz [34] reported that all cells, including
primary cells, have a heterogeneous population of EEs
carrying repetitive DNA sequence motifs. Extrachromoso-
mal DNA is a common form of DNA amplification that is
seen in a variety of different tumors [61]. For example, in
acute myelogenous leukemia, myelodysplastic syndrome,
and acute lymphoblastic leukemia, generation of EEs is
associated with disease progression [62,63]. The signifi-
cance of EEs in tumorigenicity was shown by studies
outlining the elimination of double minute–encoded c-myc
genes from the colon cancer cell line COLO 320DM, which
reduced the tumorigenicity in mice [64]. Recently, a group
of patients with advanced ovarian cancer was treated with a
noncytotoxic dose of hydroxyurea. These patients had a
45% to 60% reduction in the number of EEs, and two
patients had a stabilized disease for 6 and 10 months,
respectively [65]. The role of extrachromosomal c-myc in
tumorigenesis was also documented in a translocation-
negative mouse plasmacytoma: c-myc was transcribed
from c-myc / IgH–containing EEs, suggesting that the
functional extrachromosomal juxtaposition of c-myc and
IgH replaced the need for a chromosomal c-myc / IgH
translocation [66].
Prior to this study, the size, ultrastructure, and protein
composition of c-Myc–induced EEs were unknown. Here,
we have shown that c-Myc–induced EEs are 10- to 200-
fold larger than EEs found in non–MycER-activated Pre-B
cells (Figure 1). To date, only two ultrastructural SEM
studies on EEs have been performed: one using EEs
isolated from COLO 320DM cells and another using EEs
isolated from epidermoid KB-V1 carcinoma cells [55,56].
The EEs isolated from these two tumor cell lines have been
well characterized, in which the c-myc and multidrug
resistance genes have been identified, respectively. The
extrachromosomal DNA analyzed from COLO 320DM cells
and KB-V1 cells was 1 and 0.5 m in diameter, respectively.
These results are similar to our own SEM analysis shown
in Figure 1, in which 90% of our Pre-B+ EEs isolated were
1 m in diameter.
We show for the first time that c-Myc deregulation leads
to the de novo generation of EEs. These EEs are larger than
the ones found in non–c-Myc–activated cells [34]. Thus, c-
Myc deregulation can also promote genomic instability by
generating a pool of extrachromosomal DNA substrates for
recombination. Moreover, this study has shown that many of
these EEs carry histones and genes and have the ability to
self - replicate.
We demonstrated that the percentage of c-Myc–
induced EEs in Pre-B+ cells that carried transcriptionally
active histones was significantly higher than the percentage
found in Pre-B cells and Pre-B (abl ) cells (62.0±4.2%,
28.0±1.3%, and 9.0±2.7%, respectively). However, not all
of the Pre-B+ EEs have histone proteins on their surface.
This finding illustrates the heterogeneity of EEs isolated
from a particular cell type [34]. Western blot analysis further
confirmed the potential transcriptional capability of Pre-B+
EEs (Figure 4). These data are similar to studies using the
Rat1 fibroblast cell line containing the same MycER
construct as the one found in the Pre-B cell line, in which
c-Myc activation occurs before H4 acetylation [67]. In
addition, it has been shown that the activation of c-Myc in
mouse fibroblast 3T3 cells leads to the acetylation of
histones H3 and H4 at the cyclin D2 promoter [68].
Therefore, it seems likely that c-Myc is directly involved in
preparing the DNA for transcription through the acetylation
of histone proteins not only on the chromosomes, but also
on EEs.
The Western blot analyses data in Figure 4D indicate that
at least some of the non–c-Myc–activated Pre-B EEs are
transcriptionally competent and/or active due to a detectable
level of acetylated histone H4 protein. Because the Pre-B
cell line is immortalized, we examined EEs directly isolated
frommouse C57BL6 primary spleen cells. We did not identify
any acetylated histone H4 protein in EEs from these primary
Table 2. BrdU Incorporation and Detection of Genes on EEs.











Pre-B 7.6±3.2 3.8±1.2 3.4±1.8 7.5±2.6 4.5±1.4
Pre-B+ 56.3±6.5 48.0±6.6 30.2±3.3 51.4±9.5 10.2±6.0
This table outlines the percentage of Pre-B and Pre-B+ EEs that were detected for BrdU incorporation as well as the genes DHFR and cyclin C (as determined
by FISH-EEs) [31]. The percentages and standard errors calculated are based on a total number of 110 EEs that were counted for each sample in each
specific experiment.
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C57BL6 cells (Figure 4D, lane 7). This result suggests that
cellular immortalization may promote the formation of EEs
(see also Ref. [34] ), some of which carry H4-acetylated
protein as was detected on Pre-B EEs.
If c -Myc–activated Pre-B+ EEs contain transcriptionally
competent and/or active DNA, then it is likely that they
contain active genes and that those may be able to replicate.
Although not all genes have been identified in Pre-B+ EEs,
those identified to date are important for DNA synthesis and
cell cycle progression. In fact, we have previously shown that
Pre-B+ EEs contain genes such as R2 [22], cyclin D2 [21],
and DHFR [20], whereas Pre-B EEs do not carry these
genes. In addition, cell lines such as human breast ductal
carcinoma T47D, mouse plasmacytoma MOPC 265, and
MOPC 460D and human colorectal carcinoma line 320 HSR
have all shown c-Myc–dependent generation of DHFR -
containing EEs [20]. The present results suggest a possible
correlation between histone-containing EEs and gene-
containing EEs. We recently confirmed this correlation by
using anti–core histone antibody to isolate core histone–
containing EEs, followed by FISH analysis [53]. In the
present study, we have identified Myc- induced EEs that
carry histones and genes and are able to replicate (Table 2).
Based on our current knowledge, we propose a model of
c-Myc–dependent genomic instability (Figure 5), in which
c-Myc deregulation can lead not only to genomic instability
at the chromosomal level, but also at the extrachromosomal
level, with the potential for further genomic instability and
neoplasia. The novelty of the present study lies in the fact
that the structure of c-Myc–induced EEs is comparable to
the structure of chromosomes, and that c-Myc–induced
EEs appear to be functional genetic units, which are able to
transcribe and replicate the genes they carry and thus able to
contribute to cellular transformation. Therefore, by targeting
transcriptionally active genes that are found on EEs, it might
be possible to reduce or even eliminate the tumorigenic
potential of transformed cells in which c-Myc deregulation
plays a major role.
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